NCT00169182 Induction CT by Cisplatin, 5FU With or Without Docetaxel in Patients With T3 and T4 Larynx and Hypopharynx Carcinoma Status COMPLETED Phase PHASE3
NCT00160030 Study Comparing Radiochemotherapy With Folfox 4 Regimen or 5FU-Cisplatin in Patients With Inoperable Esophageal Cancer Status COMPLETED Phase PHASE2
NCT00159471 Genes as Predictors of Response to Gemcitabine, Docetaxel, and Capecitabine (GTX) in Metastatic or Unresectable Pancreatic Cancer. Status TERMINATED Phase NA
NCT00153881 Docetaxel and Carboplatin Followed by Oral Capecitabine, Docetaxel and Radiation for Esophageal Cancer Status COMPLETED Phase PHASE1
NCT00153803 Erlotinib or Placebo Following Chemoradiotherapy (Chemo/RT) in Stage III Non-Small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE3
NCT00150410 Demonstrate Exubera Works As Well As Avandia When Added To Sulfonylurea + Metformin In Controlling Glucose Status COMPLETED Phase PHASE3
NCT00147888 Changes in Nasal Patency With Changes in Posture, Temperature, Humidity and Nasal Patency Seen by Acoustic Rhinometry Status COMPLETED Phase PHASE4
NCT00143338 To Examine the Lung When People With Diabetes Take an Inhaled Form of Insulin, Compared to Subcutaneous Insulin. Status COMPLETED Phase PHASE2
NCT00143104 To Examine the Lung When People With Diabetes Take an Inhaled Form of Insulin, Compared to Subcutaneous Insulin. Status COMPLETED Phase PHASE2
NCT00139269 Study of Docetaxel in Combination With Cisplatin and 5-Fluorouracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck Status COMPLETED Phase PHASE1/PHASE2
NCT00139243 Study of Taxotere, Cisplatin, 5-Fluorouracil, and Leucovorin for Squamous Cell Carcinoma of the Head and Neck Status COMPLETED Phase PHASE1/PHASE2
NCT00139230 Combination Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck Status COMPLETED Phase PHASE2
NCT00138034 APRICOT-3: Antithrombotics in the Prevention of Reocclusion In COronary Thrombolysis -3 Status COMPLETED Phase PHASE4
NCT00136526 Docetaxel and Diethylstilbestrol in the Treatment of Androgen Independent Prostate Cancer Status COMPLETED Phase PHASE2
NCT00135941 Insulin Glargine Plus Insulin Glulisine Multiple Daily Injections (MDI) Versus Premix Insulin Treatment in Subjects With Diabetes Mellitus (Type 1 or Type 2) Status COMPLETED Phase PHASE3
NCT00135096 Insulin Glulisine Administered Pre-meal Versus Post-meal in Adult Subjects With Type 2 Diabetes Mellitus Receiving Insulin Glargine as Basal Insulin Status COMPLETED Phase PHASE3